ProPhase Labs Appoints New Directors, Adjusts Executive Pay
Ticker: PRPH · Form: 8-K · Filed: Jun 25, 2025 · CIK: 868278
| Field | Detail |
|---|---|
| Company | Prophase Labs, INC. (PRPH) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, management-changes
TL;DR
ProPhase Labs adds two directors and updates CEO/CFO pay packages.
AI Summary
ProPhase Labs, Inc. announced on June 25, 2025, changes in its board of directors and executive compensation. Specifically, the company elected two new directors, Dr. David G. Nichols and Mr. Robert L. Johnson, to its Board. Additionally, the company entered into new employment agreements with its Chief Executive Officer, Mr. Tedd L. Weitzman, and Chief Financial Officer, Mr. Kevin L. McGrath, detailing their compensation packages.
Why It Matters
The appointment of new directors and adjustments to executive compensation can signal strategic shifts or governance changes within ProPhase Labs, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts that may carry associated risks or opportunities.
Key Players & Entities
- ProPhase Labs, Inc. (company) — Filing company
- Dr. David G. Nichols (person) — Newly elected director
- Mr. Robert L. Johnson (person) — Newly elected director
- Mr. Tedd L. Weitzman (person) — CEO with new employment agreement
- Mr. Kevin L. McGrath (person) — CFO with new employment agreement
- June 25, 2025 (date) — Date of report and event
FAQ
Who were the newly elected directors to ProPhase Labs' Board?
Dr. David G. Nichols and Mr. Robert L. Johnson were elected as new directors to the Board of ProPhase Labs, Inc.
What is the effective date of the reported changes?
The report is dated June 25, 2025, and this is the earliest event date reported.
Which executive officers entered into new employment agreements?
Mr. Tedd L. Weitzman, the Chief Executive Officer, and Mr. Kevin L. McGrath, the Chief Financial Officer, entered into new employment agreements.
What is the principal executive office address for ProPhase Labs?
The principal executive offices are located at 626 RXR Plaza, 6th Floor, Uniondale, New York 11556.
What is the SIC code for ProPhase Labs, Inc.?
The Standard Industrial Classification (SIC) code for ProPhase Labs, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 by Dr. David G. Nichols regarding ProPhase Labs, Inc. (PRPH).